A line long warned about in the relentless march of biotechnology, is blurring further. Scientists at Columbia University, led by geneticist Dieter Egli, have conducted precise base editing on human zygotes, single-cell embryos at their earliest stage, targeting genes linked to cholesterol and haemoglobin. While framed as proof-of-concept research to refine techniques without the broader DNA damage associated with older CRISPR methods, the work has ignited fresh alarm among experts. It risks flinging open the floodgates to "designer embryos," enhancement editing, and the ultimate hubris of playing God with human life.
Proponents tout the therapeutic potential: correcting devastating genetic diseases before birth, sparing future generations from suffering. Base editing, which makes targeted single-letter changes to DNA rather than double-strand breaks, represents a technical step forward. Early applications in somatic (non-heritable) cells have shown promise, such as treating rare disorders in infants. But applying it to embryos destined for potential implantation crosses into germline editing, changes passed to all future descendants. This is no mere medical tweak; it rewrites the fundamental code of humanity.
Critics, including prominent genome-editing researchers like Alexis Komor, rightly fear the precedent. Without robust U.S. regulatory oversight, such experiments erode informal "gentleman's agreements" that have held the line against enhancement. Komor described the study as a "gateway to embryo editing to do enhancements," echoing long-standing warnings from bioethicists. The involvement of companies like Nucleus Genomics, which screens IVF embryos and has faced scrutiny for optimistic claims about genetic optimisation, only heightens concerns. What begins as disease prevention slides inexorably toward selecting for intelligence, height, athleticism, or other "desirable" traits: eugenics dressed in lab coats and venture capital.
The technical hurdles remain significant. Mosaicism, where edited embryos contain a patchwork of genetically distinct cells, persists, potentially leading to unforeseen health issues post-birth. Yet the drive continues. History shows that "for the greater good" justifications in biotechnology often outpace ethical reflection. Recall the outrage over Chinese scientist He Jiankui's 2018 CRISPR babies; today's work normalises the once-unthinkable. As one geneticist noted, the "cat's out of the bag." Regulatory gaps and commercial incentives accelerate the slide down the slope.
From a perspective rooted in humility before the complexity of life, this trajectory invites profound unease. Human embryos are not lab materials or raw genetic clay to be sculpted at will. They represent nascent persons with inherent dignity, not canvases for parental or societal preferences. The quest to eradicate suffering is noble, but when it morphs into eradicating "imperfection" or engineering superiority, it echoes darker chapters of history where science served ideology over wisdom. Who decides what counts as enhancement? What unintended consequences, genetic bottlenecks, loss of diversity, or unforeseen mutations, await generations downstream?
Philosophically and theologically, this edges close to playing God: assuming mastery over creation's blueprint. Conservative voices have long cautioned against such overreach, favouring caution, natural limits, and ethical boundaries that prioritise the vulnerable over utopian redesigns. Pro-life principles extend here: protecting life at its earliest stages from commodification. Even secular bioethics grapples with consent (impossible for the unborn), equity (only the wealthy access enhancements?), and the erosion of shared humanity.
As these floodgates widen, society faces a choice: embrace unchecked technological momentum or insist on deliberate restraint. Robust international norms, transparent oversight, and public debate, not quiet lab breakthroughs, are essential. The promise of healing must not blind us to the perils of hubris. Once germline editing for enhancement becomes routine, reversing course may prove impossible. The embryos edited today foreshadow children, and societies, reshaped tomorrow. We would do well to proceed with far greater fear and trembling, as Christian philosopher Søren Kierkegaard (1813-1855) put it in a more general context about the human condition: Fear and Trembling (Danish: Frygt og Bæven1843).
https://futurism.com/health-medicine/latest-gene-editing-human-embryos-open-floodgates